Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) on Tuesday, plunged -5.72% from the previous trading day, before settling in for the closing price of $3.32. Within the past 52 weeks, IRWD’s price has moved between $0.53 and $5.13.
During the last 5-year period, the sales drop of Healthcare Sector giant was -47.49%. The company achieved an average annual earnings per share of 1381.87%. With a float of $156.69 million, this company’s outstanding shares have now reached $162.68 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Ironwood Pharmaceuticals Inc is 3.68%, while institutional ownership is 91.65%. The most recent insider transaction that took place on Nov 17 ’25, was worth 19,973. In this transaction Chief Commercial Officer of this company sold 6,016 shares at a rate of $3.32, taking the stock ownership to the 235,264 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Officer proposed sale 6,324 for $3.37, making the entire transaction worth $21,312.
Ironwood Pharmaceuticals Inc (IRWD) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.02 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.08) by -0.06. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 1381.87% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Ironwood Pharmaceuticals Inc (IRWD) is currently performing well based on its current performance indicators. A quick ratio of 1.13 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.50. Likewise, its price to free cash flow for the trailing twelve months is 7.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.15, a number that is poised to hit 0.04 in the next quarter and is forecasted to reach 0.42 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Looking closely at Ironwood Pharmaceuticals Inc (NASDAQ: IRWD), its last 5-days average volume was 2.07 million, which is a drop from its year-to-date volume of 2.58 million. As of the previous 9 days, the stock’s Stochastic %D was 55.69%.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 86.16%, which indicates a significant increase from 75.99% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.35 in the past 14 days, which was higher than the 0.15 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.94, while its 200-day Moving Average is $1.27. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $3.29. Second resistance stands at $3.45. The third major resistance level sits at $3.57. If the price goes on to break the first support level at $3.02, it is likely to go to the next support level at $2.90. Should the price break the second support level, the third support level stands at $2.74.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
Market capitalization of the company is 509.18 million based on 162,679K outstanding shares. Right now, sales total 351,410 K and income totals 880 K. The company made 122,060 K in profit during its latest quarter, and 40,080 K in sales during its previous quarter.
